谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Corrigendum to P-207: A Multi-Center, Phase 1b Study to Assess the Safety, Pharmacokinetics and Efficacy of Subcutaneous Isatuximab Plus Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Multiple Myeloma [clinical Lymphoma Myeloma and Leukemia 21 S2 (2021) Pages S152-S153]

Philippe Moreau,Gurdeep Parmar,Miles Prince,Enrique Ocio,Chatchada Karenes,Sumit Madan,A Oriol,Pierre Bories,Michel Delforge,Nashat Galbrail,Dorothee Semiond,Nan Jia,Sandrine Macé,Florence Suzan,Helgivan de Velde

Clinical Lymphoma Myeloma and Leukemia（2022）

引用 0|浏览2
关键词
International Myeloma Working Group
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要